尊龙凯时
About us
尊龙凯时:Our Values
尊龙凯时:Development Milestone
Products
尊龙凯时:Product List for API
尊龙凯时:Recommended API
尊龙凯时:Product list for Chemicals and Intermediates
Product list for Chemicals and Intermediates
News
尊龙凯时:Contract Manufacturing
尊龙凯时:API and Pharmaceutical Intermediates
尊龙凯时:OTC and Generics
尊龙凯时:Investor Relation
尊龙凯时:PERIODIC REPORT
尊龙凯时:INTERIM REPORT
尊龙凯时:INVESTORS SERVICE
尊龙凯时:Contact Us
About us
News
尊龙凯时:Investor Relation
Products
尊龙凯时:Contract Manufacturing
尊龙凯时:Contact Us
Investor Relation
Investor Relation
尊龙凯时:PERIODIC REPORT
尊龙凯时:INTERIM REPORT
INVESTORS SERVICE
Overseas Regulatory Announcement-Announcement on Drugs of Wholly-owned Subsidiar
2023-09-20
Monthly Return of Equity Issuer on Movements in Securities for the month ended 3
2023-09-01
Announcement Notice of Board Meeting
2023-08-14
Overseas Regulatory Announcement-Announcement on Alogliptin Benzoate Tablets Obt
2023-08-11
Supplemental Announcement In Relation To Annual Report For The Year Ended 31 Dec
2023-08-07
Monthly Return of Equity Issuer on Movements in Securities for the month ended 3
2023-08-01
List of Directors And Their Roles And Functions
2023-07-26
Resignation of Independent Non-executive Director and Ceased to Act as Members o
2023-07-26
Announcement on Rabeprazole Sodium Enteric-coated Tablets (20mg) Passing the Gen
2023-07-14
Overseas Regulatory Announcement-Announcement on New Drug Specifications and Pas
2023-07-10
<
...
8
9
10
11
12
13
14
...
>